Pedzisai Munatsi

Dados Biográficos

ID8932882
NOMEPedzisai Munatsi
PRENOMESPedzisai
SOBRENOMEMunatsi
ASSINATURAMUNATSI P
AFILIAÇÕESCentre for the AIDS Programme of Research in South Africa
VERIFICADONão
TOTAL DE OBRAS3
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR3
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2024
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H0

  • Point-of-care HIV viral load testing in a community antiretroviral therapy delivery programme

    Open AccessJienchi Dorward, Kwena Tlhaku et al.ARTICLEPLOS Global Public Health2026

    Community antiretroviral therapy (ART) delivery programmes allow people with HIV (PWH) to collect treatment nearer to home instead of from clinics. However, delays in laboratory-based viral load (VL) testing can prevent timely community ART prescription renewals. We aimed to determine if clinic point-of-care VL testing could expedite community ART prescription renewals within the Centralised Chronic Medication Dispensing and Distribution programm…

  • Acceptability and perspectives on clinic-based urine tenofovir testing for antiretroviral therapy adherence monitoring

    Ashley R Bardon, Ashley Bardon et al.ARTICLEAIDS Care2026

    Real-time, urine tenofovir testing may allow for clinic-based monitoring of adherence to antiretroviral therapy (ART). We aimed to assess (1) the acceptability of monthly point-of-care urine tenofovir testing over the first five months following ART initiation and (2) perspectives on the implementation of point-of-care urine tenofovir testing among people living with HIV (PLWH) and healthcare providers participating in a randomized controlled tri…

  • Healthcare worker perspectives on adaptations to differentiated anti-retroviral therapy delivery during Covid-19 in South Africa

    Open AccessKwena Tlhaku, Lindani Msimango et al.ARTICLEPLOS Global Public Health2024

    During the COVID-19 pandemic, the South African Centralized Chronic Medicines Dispensing and Distribution (CCMDD) programme, adapted to include extended 12-month antiretroviral therapy (ART) prescriptions, 3-months ART refills and earlier eligibility criteria at 6-months after ART initiation. We aimed to explore the experiences of healthcare workers (HCWs) in implementing these adaptations, and to understand the overall impact of COVID-19 on CCMD…